Alector Overview
Valuation check: ALEC's ROE is 1182.09%, above the Healthcare sector average of 20.86%.
Get informed when a big investor buys or sells
+ Follow1182.09%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Alector (ALEC) currently reports a ROE of 1182.09%. That is above the Healthcare sector average of 20.86%. Use the charts on this page to explore Alector's ROE history and peer comparisons.
Alector's ROE of 1182.09% is higher than the Healthcare sector average of 20.86%. That is roughly 5567.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Alector's current 1182.09% should be judged against Healthcare norms (sector average: 20.86%) and against ALEC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 1182.09%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.86%. From there, open related valuation or income-statement pages for Alector, and consider following ALEC for alerts when major investors trade the stock.
Alector is classified in the Healthcare sector. On ROE, it currently shows 1182.09% versus a sector average near 20.86%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALEC with unrelated industries.
